Navidea Biopharmaceuticals Depreciation & Amortization 2011-2026 | NAVB

Annual Depreciation & Amortization Navidea Biopharmaceuticals

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
48.2 K	36.8 K	33.9 K	103 K	121 K	232 K	496 K	562 K	488 K	400 K	199 K	175 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
562 K	33.9 K	241 K

Quarterly Depreciation & Amortization Navidea Biopharmaceuticals

2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
27 K	27.1 K	27.6 K	-	24.7 K	21.8 K	22.9 K	-	55.7 K	37.6 K	17.7 K	-	51.5 K	36.1 K	16.8 K	-	108 K	73.5 K	36.8 K	-	113 K	75.5 K	38 K	-	212 K	162 K	86.5 K	-	379 K	267 K	150 K	-	132 K	149 K	150 K	-	361 K	235 K	111 K	-	320 K	235 K	76.1 K	-	139 K	87.1 K	33.9 K	-	151 K	110 K	59.6 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
379 K	16.8 K	113 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
AbCellera Biologics ABCL	18.4 M	$ 3.56	-	$ 1.06 B	Canada
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	7 K	-	4.01 %	$ 150 M	Canada
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
AgeX Therapeutics AGE	131 K	-	-10.17 %	$ 12.2 K	USA
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	63 K	-	10.36 %	$ 9.8 M	USA
Aptorum Group Limited APM	1.13 M	$ 0.79	0.01 %	$ 4.31 M	China
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
Atea Pharmaceuticals AVIR	416 K	$ 6.05	-	$ 493 M	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
Arcturus Therapeutics Holdings ARCT	3.02 M	$ 6.63	-	$ 182 M	Israel
BioCardia BCDA	84 K	$ 1.27	-	$ 26.9 M	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Athersys ATHX	1.43 M	-	3.77 %	$ 22.4 M	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Acer Therapeutics ACER	66 K	-	2.71 %	$ 14 M	USA
ARCA biopharma ABIO	27 K	-	1052.0 %	$ 415 M	USA
Allena Pharmaceuticals ALNA	363 K	-	3.16 %	$ 1.9 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
AlloVir ALVR	398 K	-	4.14 %	$ 49.1 M	USA
Catalyst Biosciences CBIO	2.48 M	$ 11.58	-	$ 1.03 B	USA
Cerus Corporation CERS	1.43 M	$ 1.8	6.51 %	$ 343 M	USA
Anika Therapeutics ANIK	6.43 M	$ 14.36	-	$ 210 M	USA
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
Aptose Biosciences APTO	32 K	-	-45.71 %	$ 1.2 M	Canada
AVEO Pharmaceuticals AVEO	67 K	-	-	$ 521 M	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
CNS Pharmaceuticals CNSP	3.31 K	$ 2.45	0.41 %	$ 936 K	USA
Aytu BioScience AYTU	5.38 M	$ 2.64	-	$ 16.6 M	USA
Cardiff Oncology CRDF	364 K	$ 1.9	-	$ 127 M	USA
CorMedix CRMD	677 K	$ 6.54	-	$ 471 K	USA
Autolus Therapeutics plc AUTL	7.55 M	$ 1.51	-	$ 385 M	Britain